Latest news

Thumbnail image for Four new medicines cleared for use on NHS Scotland

Four new medicines cleared for use on NHS Scotland

The Scottish Medicines Consortium has approved funding for four newly licensed medicines, expanding NHS treatments options in Scotland for ovarian cancer, lung cancer, urea cycle disorders and acute hereditary angioedema.

14th August 2018

Thumbnail image for Motif Bio’s antibiotic granted US priority review

Motif Bio’s antibiotic granted US priority review

US regulators have accepted for review a targeted, Gram-positive investigational antibiotic developed by UK biopharma Motif Bio for the treatment of acute bacterial skin and skin structure infections (ABSSSI).

14th August 2018

Thumbnail image for Amicus’ Galafold wins US approval

Amicus’ Galafold wins US approval

Amicus Therapeutics’ Galafold has been approved in the US as the first oral medication for the treatment of adults with Fabry disease.

13th August 2018

Thumbnail image for Astellas buys UK group Quethera

Astellas buys UK group Quethera

Astellas has acquired Cambridge, UK-based Quethera, a gene therapy group focused on the development of novel treatments for ocular disorders, such as glaucoma.

13th August 2018

Previous  --   10 11 12 13 14 15 16 17 18 19   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download